Influenza Virus Vaccine, H5N1 and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Influenza Virus Vaccine, H5N1 and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: influenza virus vaccine, h5n1
Brand name: Influenza Virus Vaccine, H5N1, Inactivated
Synonyms: Influenza A Virus Vaccine (H5N1)
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Influenza Virus Vaccine, H5N1-Insulin glargine, recombinant Subcutaneous
- Influenza Virus Vaccine, H5N1-Insulin glulisine
- Influenza Virus Vaccine, H5N1-Insulin Glulisine (Cartridges and Pens)
- Influenza Virus Vaccine, H5N1-Insulin Glulisine (Vials)
- Influenza Virus Vaccine, H5N1-Insulin glulisine Subcutaneous
- Influenza Virus Vaccine, H5N1-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Influenza virus vaccine, live Nasal
- Insulin glargine and lixisenatide Subcutaneous-Infugem
- Insulin glargine and lixisenatide Subcutaneous-Infumorph
- Insulin glargine and lixisenatide Subcutaneous-Infumorph injection
- Insulin glargine and lixisenatide Subcutaneous-Infuvite Adult
- Insulin glargine and lixisenatide Subcutaneous-Infuvite Pediatric